Literature DB >> 6743471

Is circadian variation in theophylline trough serum concentrations determined by time of dosing?

S H Jackson, J K Wiffen, M M Smythe, A Johnston.   

Abstract

Ten healthy volunteers were each given two separate courses of eight doses of theophylline 200 mg as a slow release preparation at 12 hourly intervals. In the first course (regimen 1) the dose was given at 11.00 h and 23.00 h and in the second (regimen 2) at 05.00 h and 17.00 h. Sixty hours after the start of each course, four consecutive trough serum theophylline concentrations were measured. On regimen 1 the trough concentration of theophylline was 6.2 +/- 2.2 mg/l (mean +/- s.d.) at 11.00 h compared with 5.4 +/- 1.9 mg/l at 23.00 h (P less than 0.01). This circadian variation was abolished during regimen 2 when the mean theophylline concentrations were identical at 5.2 mg/l. The higher trough concentrations after the evening dose on regimen 1 and the loss of circadian variation on regimen 2 may be due to the change in sleep period in relation to the time of dosing.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6743471      PMCID: PMC1463435          DOI: 10.1111/j.1365-2125.1984.tb02419.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Influence of diet and fluid on bioavailability of theophylline.

Authors:  P G Welling; L L Lyons; W A Craig; G A Trochta
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

2.  Investigation of diurnal changes in the disposition of theophylline.

Authors:  D R Taylor; D Duffin; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

3.  Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet.

Authors:  M Lagas; J H Jonkman
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.

Authors:  D R Taylor; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

5.  Pharmacokinetics of theophylline in night-workers.

Authors:  S Decourt; F Fodor; B Flouvat; A Pradalier; J Dry
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

6.  Temporal variations in trough serum theophylline concentrations at steady state.

Authors:  L J Lesko; D Brousseau; A T Canada; G Eastwood
Journal:  J Pharm Sci       Date:  1980-03       Impact factor: 3.534

7.  Physiological and pharmacological variability in estimated hepatic blood flow in man.

Authors:  T K Daneshmend; L Jackson; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

  7 in total
  3 in total

1.  Circadian variation in theophylline absorption during chronic dosing with a slow release theophylline preparation and the effect of clock time of dosing.

Authors:  S H Jackson; A Johnston; R Woollard; S M Abrams; P Turner
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

2.  Circadian variation in theophylline 'trough' serum concentrations.

Authors:  M H Smolensky; J H Jonkman; P H Scott
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

3.  Comparison of single and multiple dose pharmacokinetics of theophylline using stable isotopes.

Authors:  R E Vestal; K E Thummel; G D Mercer; J R Koup
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.